HELLO GORGEOUS MED SPA • RX
Book Free Consult →Doctor-guided GLP-1 care • Illinois Licensed
Weight loss,
simplified with
personalized care.
A smarter approach to GLP-1 therapy — built around your day in Oswego. Clinician-approved, fairly priced, screened like a medical practice.
Three simple steps from intake to doorstep.
Start your intake
Share health history and goals in a short online intake. No credit card needed, no waiting room. Screening like a medical practice.
Licensed IL provider reviews
NP on-site 6 days + Dr Arora MD oversight reviews your intake and writes prescription if eligible. We turn away 1 in 12 if not appropriate.
Ships from U.S. 503A pharmacy
Compounded and shipped discreet, unmarked packaging with ongoing clinician support and secure messaging.
Tirzepatide
Weight Loss
Compounded tirzepatide therapy — dual GIP and GLP-1 receptor agonist prescribed by licensed IL provider and shipped from U.S. 503A pharmacy.
What it is
A compounded tirzepatide program supervised by licensed IL clinician. Individualized, titrated over weeks, paired with ongoing care. Compounded preparation is not FDA-approved, not generic, not substitute, not equivalent of any FDA-approved product. Prescription only under qualified supervision.
How it works
Dual agonist: activates GIP and GLP-1 receptors influencing appetite, satiety, insulin, gastric emptying. Distinct mechanism vs single-pathway GLP-1. SURMOUNT trials showed meaningful weight reduction with nutrition/lifestyle. Individual results vary by starting point, dose, tolerance, diet, movement, sleep.
Who it's for
IL adults 21+ BMI 30+ or 27+ with weight-related condition (T2D, HTN, high cholesterol). Not for pregnant, planning, breastfeeding. Not for MTC, MEN2, pancreatitis history. Provider screens 20+ contraindications.
What to expect
Once-weekly subcutaneous injection titrated gradually low → up to minimize side effects. Common: nausea, constipation, reflux, diarrhea, fatigue during dose increases, usually mild transient. Secure messaging — clinician can slow titration, hold, adjust.
Semaglutide
Weight Loss
The original GLP-1 for sustainable weight management. Starter-friendly dosing from licensed IL clinician. STEP trials ~15% mean weight loss over 68 weeks.
What it is
Single GLP-1 receptor agonist, starter-friendly, titrated gradually. Not FDA-approved compounded version — not generic of Wegovy®.
How it works
Mimics natural GLP-1 released after eating — stimulates insulin, lowers blood sugar, tells brain reduce cravings, slows gastric emptying, central appetite control. STEP trials Garvey 2022 showed 15.2% mean change at week 104.
Safety
Same class warnings: pancreatitis, gallbladder, kidney injury from dehydration, allergic reactions, thyroid C-cell boxed warning rodent studies. Tell provider all meds/supplements.
One price. No contracts. Cancel anytime.
Pay monthly. Pause whenever. Free intake, free shipping, ongoing relationship with prescribing clinician included.
The original GLP-1 for sustainable weight management. Starter-friendly dosing.
- ✓ Provider consultation included
- ✓ Free discreet shipping
- ✓ Monthly titration support
Dual-receptor therapy for patients ready to make real push toward goal weight.
- ✓ Provider consultation included
- ✓ Free discreet shipping
- ✓ Adjustable dose protocol
100 mg/mL longevity support — sterile for subcutaneous use.
Add to planCommon questions.
Where is Hello Gorgeous Med Spa located?
74 W Washington St, Oswego IL 60543 — serving Naperville, Aurora, Plainfield, Kendall County. Free parking.
Is this FDA-approved or compounded?
We prescribe FDA-approved Wegovy® and Zepbound® when clinically appropriate and available. Compounded semaglutide/tirzepatide via 503A pharmacy only when appropriate per clinician judgment. Compounded not FDA-approved.
Who provides oversight?
Dr Mukesh Arora MD 30+ years Internal Medicine is Medical Director. Owner Danielle Alcala-Glazier RN-S leads daily practice. NP on-site 6 days.
What's the difference between Tirzepatide and Semaglutide?
Tirzepatide dual GIP/GLP-1, SURMOUNT trials 16-22.5% weight reduction. Semaglutide single GLP-1, STEP trials ~15%. Different mechanisms — not necessarily better for every patient.